首页/数据集/IPTi impact below 10 years of age, in a high transmission region, under different intervention coverage.

IPTi impact below 10 years of age, in a high transmission region, under different intervention coverage.

Figshare2015-12-02 更新2026-05-11 收录

数据链接：

https://figshare.com/articles/dataset/_IPTi_impact_below_10_years_of_age_in_a_high_transmission_region_under_different_intervention_coverage_/558745 数据链接链接失效反馈

官方服务：

资源简介：

IPTi impact below 10 years of age, in a high transmission region, under different intervention coverage.

应用场景：

创建时间：

2015-12-02

疟疾化学预防效果评估

药代动力学模拟

Predictions related to trough and peak capillary plasma concentration of PQ at steady-state with various chemoprevention regimens of DP in 1–2 year olds weighing ≥ 11 kg.

NIAID Data Ecosystem50

Prevalence of molecular markers of resistance to sulphadoxine, pyrimethamine and amodiaquine at post-SMC in the SMC population vs . concurrent Non-SMC patient population.

耐药性监测

疟疾化学预防效果评估

Prevalence of molecular markers of resistance to sulphadoxine, pyrimethamine and amodiaquine at post-SMC in the SMC population vs. concurrent Non-SMC patient population.

NIAID Data Ecosystem40

Supporting Information S1 - Modelling the Protective Efficacy of Alternative Delivery Schedules for Intermittent Preventive Treatment of Malaria in Infants and Children

疟疾化学预防效果评估

传染病模型

Extended Methods, Results and Sensitivity Analysis. (DOCX)

Figshare2015-12-02 更新30

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second round of the MDA, during the Ebola outbreak, Monrovia, Liberia, 2014 (Poisson regression).

疟疾化学预防效果评估

用药依从性

Association between experiencing side effects of artesunate/amodiaquine malaria chemoprevention (ASAQ-CP) in the first round of mass drug administration (MDA) with initiation of ASAQ-CP in the second

NIAID Data Ecosystem50

Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali

疟原虫抗药性监测

疟疾化学预防效果评估

Background Seasonal malaria chemoprevention (SMC) with sulphadoxine-pyrimethamine (SP) plus amodiaquine (AQ) is being scaled up in Sahelian countries of West Africa. However, the potential development

NIAID Data Ecosystem30

IPTi impact below 10 years of age, in a high transmission region, under different intervention coverage.

资源简介：

相关数据集